Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Operating Expenses | 3,495 | 2,448 | 0 | 3,321 | 3,249 |
| Operating Income | -3,495 | -2,448 | N/A | -3,321 | -3,249 |
| Interest Expense | 404 | 378 | 0 | 378 | 378 |
| Other Income | 180 | 13 | 0 | 9 | 7 |
| Pre-tax Income | -3,718 | -2,813 | 0 | -3,691 | -3,620 |
| Income Tax | N/A | -3,653 | N/A | N/A | N/A |
| Net Income Continuous | -3,718 | 839 | N/A | -3,691 | -3,620 |
| Net Income | $-3,718 | $839 | $N/A | $-3,691 | $-3,620 |
| EPS Basic Total Ops | -920.00 | 200.00 | N/A | -143,340.00 | -140,580.00 |
| EPS Basic Continuous Ops | -929.59 | 15,789.69 | N/A | -143,340.80 | -140,580.50 |
| EPS Diluted Total Ops | -920.00 | 20.00 | N/A | -143,340.00 | -140,580.00 |
| EPS Diluted Continuous Ops | -929.59 | 2,041.63 | N/A | -143,340.80 | -140,580.50 |
| EBITDA(a) | $-3,492 | $-2,445 | $N/A | $-3,318 | $-3,249 |